Keyphrases
Antimalarial Drugs
25%
Artemether-lumefantrine
25%
Drug Policy
25%
Drug Resistance
100%
Enhanced Tolerance
25%
Ghana
100%
Ghanaians
25%
Increased Dose
25%
Intermittent Preventive Treatment
25%
Molecular Markers
100%
Molecular Resistance Mechanism
25%
Pfcrt
25%
Pfcrt Gene
25%
Pfdhfr
50%
Pfdhps
75%
Pfmdr1
50%
Pregnant Women
100%
Quintuple
25%
Resistance Markers
75%
Single nucleotide Polymorphism Haplotypes
25%
Sulfadoxine-pyrimethamine
25%
Treatment Options
25%
Women in Ghana
25%
Medicine and Dentistry
Antimalarial
33%
Antimalarial Agent
33%
Antimalarial Drug Resistance
33%
Artemether/Lumefantrine
33%
Cross Sectional Study
33%
Drug Resistance
100%
Haplotype
66%
Infection
33%
Molecular Marker
100%
Prevalence
100%
Prophylaxis
33%
Single Nucleotide Polymorphism
33%
Sulfadoxine/Pyrimethamine
33%
Immunology and Microbiology
Antimalarial Agent
33%
Antimalarial Drug Resistance
33%
Artemether
33%
Drug Resistance
100%
Genetic Marker
100%
Haplotype
66%
Prevalence
100%
Single Nucleotide Polymorphism
33%
Sulfadoxine/Pyrimethamine
33%
Wild Type
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antimalarial Agent
100%
Artemether Plus Benflumetol
33%
Cross-Sectional Study
33%
Drug Resistance
100%
Infection
33%
Molecular Marker
100%
Prevalence
100%
Pyrimethamine Plus Sulfadoxine
33%